Kenneth Ain: Clinical Trials

2 trials sponsored by Kenneth Ain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Kenneth Ain: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Lenalidomide - Thyroid Neoplasms
Phase 2CompletedKenneth Ain252006-02-012020-06-12
Thalidomide in Treating Patients With Thyroid Cancer
thalidomide - Head and Neck Cancer
Phase 2CompletedKenneth Ain2001-06-012017-06-06

Conditions studied

Thyroid Neoplasms (2)  ·  Adenocarcinoma, Follicular (1)  ·  Carcinoma, Medullary (1)  ·  Head and Neck Neoplasms (1)  ·  Thyroid Cancer, Papillary (1)

Interventions

Lenalidomide (1)  ·  Thalidomide (1)

Countries

United States (2)

Top investigators

Kenneth B Ain, M.D. (1)